A previous study demonstrated that the expression of PBLD was significantly decreased in mice with DSS-induced colitis; however, its repressive action on NF-κB signaling could improve intestinal barrier function and alleviate intestinal inflammation [45]. The gene discussed is NFKB1; the disease is inflammatory response.